DMTK Insider Trading Activity and SEC Form 4 Filings
DMTK insider trading summary
No open-market insider purchases or sales of DermTech, Inc. (DMTK) have been reported on SEC Form 4 in the past 12 months.
Latest DMTK insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 11, 2023 | Claudia Ibarra | Chief Operating Officer | Sell | $480 (331 @ $1.45) |
| Dec 11, 2023 | Kevin M Sun | Chief Financial Officer | Sell | $648 (447 @ $1.45) |
| Dec 8, 2023 | Claudia Ibarra | Chief Operating Officer | Sell | $4K (2,607 @ $1.41) |
| Dec 7, 2023 | Kevin M Sun | Chief Financial Officer | Sell | $3K (2,248 @ $1.53) |
| Dec 7, 2023 | Claudia Ibarra | Chief Operating Officer | Sell | $3K (1,768 @ $1.53) |
| Dec 7, 2023 | Kevin M Sun | Chief Financial Officer | Sell | $288 (188 @ $1.53) |
| Dec 7, 2023 | Ramin Akhavan | General Counsel | Sell | $3K (1,768 @ $1.53) |
| Dec 7, 2023 | Claudia Ibarra | Chief Operating Officer | Sell | $3K (2,000 @ $1.53) |
| Dec 7, 2023 | Ramin Akhavan | General Counsel | Sell | $3K (2,000 @ $1.53) |
| Dec 7, 2023 | Kevin M Sun | Chief Financial Officer | Sell | $4K (2,543 @ $1.53) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.